These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 29480180)

  • 1. The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.
    Alegret M; Peretó M; Pérez A; Valero S; Espinosa A; Ortega G; Hernández I; Mauleón A; Rosende-Roca M; Vargas L; Rodríguez-Gómez O; Abdelnour C; Berthier ML; Bak TH; Ruíz A; Tárraga L; Boada M
    J Alzheimers Dis; 2018; 62(2):611-619. PubMed ID: 29480180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals.
    García-Herranz S; Díaz-Mardomingo MC; Venero C; Peraita H
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2020 Nov; 27(6):826-840. PubMed ID: 31822214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease.
    Mirandez RM; Aprahamian I; Talib LL; Forlenza OV; Radanovic M
    Int Psychogeriatr; 2017 Jun; 29(6):949-958. PubMed ID: 28179036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal fluency in the detection of mild cognitive impairment and Alzheimer's disease among Brazilian Portuguese speakers: the influence of education.
    Radanovic M; Diniz BS; Mirandez RM; Novaretti TM; Flacks MK; Yassuda MS; Forlenza OV
    Int Psychogeriatr; 2009 Dec; 21(6):1081-7. PubMed ID: 19619390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological predictors of conversion to probable Alzheimer disease in elderly with mild cognitive impairment.
    García-Herranz S; Díaz-Mardomingo MC; Peraita H
    J Neuropsychol; 2016 Sep; 10(2):239-55. PubMed ID: 25809316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semantic and Phonemic Verbal Fluency Discrepancy in Mild Cognitive Impairment: Potential Predictor of Progression to Alzheimer's Disease.
    Vaughan RM; Coen RF; Kenny R; Lawlor BA
    J Am Geriatr Soc; 2018 Apr; 66(4):755-759. PubMed ID: 29572820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).
    Moreira HS; Costa AS; Machado Á; Castro SL; Lima CF; Vicente SG
    PLoS One; 2019; 14(9):e0221873. PubMed ID: 31504056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Stability of Mild Cognitive Impairment (MCI): Findings of a Community Based Sample.
    Ellendt S; Voβ B; Kohn N; Wagels L; Goerlich KS; Drexler E; Schneider F; Habel U
    Curr Alzheimer Res; 2017; 14(6):608-619. PubMed ID: 27978792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of cognitive tests, individually and combined, for the detection of cognitive disorders amongst community-dwelling elderly people with memory complaints: the EVATEM study.
    Vannier-Nitenberg C; Dauphinot V; Bongue B; Sass C; Bathsavanis A; Rouch I; Deville N; Beauchet O; Krolak-Salmon P; Fantino B
    Eur J Neurol; 2016 Mar; 23(3):554-61. PubMed ID: 26518736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.